Your fact-checks will appear here
The effectiveness of the ketogenic diet as a treatment for cancer.
Ivermectin and fenbendazole show repeated anticancer activity in laboratory studies and scattered preclinical models, but high-quality human evidence is essentially absent and professional oncology gu...
Laboratory and animal studies report that ivermectin and fenbendazole can kill cancer cells and boost certain chemotherapy effects, but there is no robust human evidence confirming safety or benefit w...
Preclinical literature shows produces the most robust anticancer signals in (including triple‑negative), , , , (non‑small cell) and certain models, largely because it targets multiple survival and res...
report that ivermectin produces across many models, most commonly using mouse doses with a median of ~5 mg/kg (range ~2.4–40 mg/kg) given over multi‑day courses and by several routes, which translate ...
in the sense of being an empty product: it is a real, nutrient-dense plant used for centuries with laboratory and some human data showing antioxidant, anti‑inflammatory, and metabolic effects . Howeve...
Patients who substitute ivermectin for proven cancer therapies have documented harms that fall into three categories: direct drug toxicity from unsupervised or high-dose use, dangerous drug–drug inter...
Black garlic is an aged form of Allium sativum produced by controlled heat and humidity that turns cloves black while transforming their chemistry and flavor; the process increases stable antioxidant ...
as an anticancer agent is nascent: small, early-phase combination trials have used oral, pulsed schedules (for example, days 1–3, 8–10, 15–17 of a 21‑day cycle) alongside immune checkpoint inhibitors,...
Peer-reviewed evidence shows the (KD) has credible, disease-specific support—strongest for , moderate and mixed for short-term , nonalcoholic fatty liver disease () and some cognitive outcomes, and li...
Patients who substitute ivermectin for evidence-based have suffered documented harms including (notably neurological effects at high doses and common gastrointestinal/skin reactions), dangerous drug–d...
There is no clinical evidence supporting long-term ivermectin use for cancer prevention, and medical authorities have not approved it for that purpose; therefore treating oneself chronically with iver...
Preclinical research ties ’s anticancer activity to at least three interlocking mechanisms: suppression of Wnt/β‑catenin signaling, inhibition of the PAK1/Akt/mTOR axis with induction of autophagy/apo...
Ivermectin’s proposed anticancer effects rest on a bundle of mechanistic observations from cell and animal studies: direct disruption of tumor cell signaling and ion-homeostasis that triggers apoptosi...
Ivermectin is both a substrate and inhibitor of P‑glycoprotein (ABCB1/P‑gp), and preclinical work identifies chemotherapies that rely on P‑gp for cellular efflux—most notably taxanes and vinca alkaloi...
Ivermectin is an antiparasitic medicine approved for specific human infections and widely used in veterinary medicine; its safety and dosing are established for those approved indications, not for vir...
Oncology specialists evaluate integrative approaches by asking whether individual therapies are evidence-informed, safe alongside standard treatment, and supported by clinical guidelines — not by pati...